FR2419071A1 - Extrait cellulaire bacterien, procede de preparation, preparation antitumorale et preparation adjuvante le contenant - Google Patents

Extrait cellulaire bacterien, procede de preparation, preparation antitumorale et preparation adjuvante le contenant

Info

Publication number
FR2419071A1
FR2419071A1 FR7906141A FR7906141A FR2419071A1 FR 2419071 A1 FR2419071 A1 FR 2419071A1 FR 7906141 A FR7906141 A FR 7906141A FR 7906141 A FR7906141 A FR 7906141A FR 2419071 A1 FR2419071 A1 FR 2419071A1
Authority
FR
France
Prior art keywords
preparation
tumor
extract
container
adjusting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7906141A
Other languages
English (en)
French (fr)
Other versions
FR2419071B1 (https=
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Toatsu Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Publication of FR2419071A1 publication Critical patent/FR2419071A1/fr
Application granted granted Critical
Publication of FR2419071B1 publication Critical patent/FR2419071B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7906141A 1978-03-10 1979-03-09 Extrait cellulaire bacterien, procede de preparation, preparation antitumorale et preparation adjuvante le contenant Granted FR2419071A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2651978A JPS54140710A (en) 1978-03-10 1978-03-10 Anti-tumor substance and its preparation

Publications (2)

Publication Number Publication Date
FR2419071A1 true FR2419071A1 (fr) 1979-10-05
FR2419071B1 FR2419071B1 (https=) 1983-02-11

Family

ID=12195716

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7906141A Granted FR2419071A1 (fr) 1978-03-10 1979-03-09 Extrait cellulaire bacterien, procede de preparation, preparation antitumorale et preparation adjuvante le contenant

Country Status (7)

Country Link
US (1) US4726947A (https=)
JP (1) JPS54140710A (https=)
CA (1) CA1146467A (https=)
DE (2) DE2908241C2 (https=)
FR (1) FR2419071A1 (https=)
GB (1) GB2015876B (https=)
IT (1) IT1110450B (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5632489A (en) * 1979-08-28 1981-04-01 Mitsui Toatsu Chem Inc Antitumor active substance and its pharmaceutical
JPS5632490A (en) * 1979-08-28 1981-04-01 Mitsui Toatsu Chem Inc Antitumor active substance and its pharmaceutical
FR2466247A1 (fr) * 1979-10-03 1981-04-10 Decroix Guy Preparation immuno-stimulante et application
DE3048699C2 (de) * 1980-12-23 1985-03-28 Chisato Tokio/Tokyo Maruyama Immuntherapeutisches Mittel gegen Tumore, enthaltend als wirksame Komponente ein Lipopolysaccharid
KR940005589B1 (ko) * 1986-04-02 1994-06-21 다이닛뽄세이야꾸 가부시끼가이샤 핵산 또는 엔도톡신의 제거제 및 제거방법
US5527770A (en) * 1993-08-06 1996-06-18 International Gene Group, Inc. Immunotherapeutic agent derived from bacteria
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
DE4422859C2 (de) * 1994-06-30 2000-10-05 Laves Arzneimittel Gmbh Wäßrige Zellextrakte aus Mykobacterien
US5759992A (en) * 1994-08-31 1998-06-02 David Platt Immunotherapeutic agent derived from bacteria and method for its manufacture
CA2160082C (en) * 1994-10-07 1998-11-10 Melvin E. Klegerman Mixture having antitumor activities
DE69530107T2 (de) 1994-12-28 2003-10-16 University Of Kentucky, Lexington Monoklonaler anti-idiotypischer antikörper 3h1 aus maus
AU1830595A (en) * 1995-01-09 1996-07-31 International Gene Group, Inc. Immunotherapeutic agent derived from bacteria
US6949244B1 (en) 1995-12-20 2005-09-27 The Board Of Trustees Of The University Of Kentucky Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
US20020041872A1 (en) * 1996-04-12 2002-04-11 Malaya Chatterjee Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
US6235280B1 (en) 1996-04-12 2001-05-22 Malaya Chatterjee Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
CN1153574C (zh) * 1997-04-02 2004-06-16 比奥尼斯生命科学公司 细菌细胞壁提取物在制备预防,治疗或排除原生动物或寄生虫疾病的药物组合物上的应用
ATE236922T1 (de) * 1997-06-03 2003-04-15 Itochu Techno Chem Inc Natürliche antitumor- oder antivirale substanzen und ihre anwendung
US6274143B1 (en) 1997-06-13 2001-08-14 Malaya Chatterjee Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10
US20020098190A1 (en) * 1997-06-13 2002-07-25 Malaya Chatterjee Compositions and methods for treating tumors bearing HMFG and CEA antigens
US20020122807A1 (en) * 1998-07-07 2002-09-05 Dan Michael D. Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
JP4335435B2 (ja) 1997-08-05 2009-09-30 バイオニケ ライフ サイエンシーズ インコーポレイテッド 細胞増殖および細胞死を調節する組成物および方法
US6355244B1 (en) 1997-11-17 2002-03-12 University Of Kentucky Research Foundation Methods and compositions for the treatment of psoriasis
US7026155B2 (en) 1999-02-02 2006-04-11 Regents Of The University Of California Method of reducing bacterial proliferation
US20020068068A1 (en) * 1999-02-02 2002-06-06 Mahan Michael J. Method of creating antibodies and compositions used for same
AU785212B2 (en) * 1999-12-13 2006-11-09 Bioniche Life Sciences Inc. Therapeutically useful synthetic oligonucleotides
WO2001047561A1 (en) * 1999-12-28 2001-07-05 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
WO2003009859A1 (en) * 2001-07-19 2003-02-06 Azuma, Ichiro Immunotherapy for humans
US7153265B2 (en) * 2002-04-22 2006-12-26 Medtronic Minimed, Inc. Anti-inflammatory biosensor for reduced biofouling and enhanced sensor performance
US20040265337A1 (en) * 2002-08-21 2004-12-30 Zsebo Krisztina M. Method of generating an immune response and compositions used for same
JP4912875B2 (ja) * 2004-02-27 2012-04-11 不二製油株式会社 癌転移抑制組成物
CN102441162B (zh) * 2010-10-04 2018-07-24 免疫产品美国股份有限公司 结核病的治疗和预防
EP2679232A1 (en) * 2012-06-29 2014-01-01 Lysando Aktiengesellschaft Composition for use in Mycobacteria vaccination
EP2679677A1 (en) * 2012-06-29 2014-01-01 Lysando Aktiengesellschaft Composition for use in Mycobacteria therapy
US9388400B2 (en) 2012-06-29 2016-07-12 Lysando Ag Composition for use in mycobacteria diagnosis
US20170167013A1 (en) * 2014-02-12 2017-06-15 Hyeong Gon LEE Apparatus for manufacturing thin film cluster, thin film cluster, thin film, uv-blocking agent and cosmetics
CN114621946B (zh) * 2022-04-07 2023-07-04 施可丰化工股份有限公司 一种防治大豆根腐病的生防菌剂及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2189021A1 (en) * 1972-06-20 1974-01-25 Anvar Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3399263A (en) * 1965-04-12 1968-08-27 American Cyanamid Co Stable adjuvant emulsion compositions comprising the hydrated reaction products of a methallic cation and a fatty acid
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
US3790665A (en) * 1968-02-23 1974-02-05 Haver Lockhart Labor Inc Injectable adjuvant,method of preparing same and compositions including such adjuvant
GB1426042A (en) * 1971-11-26 1976-02-25 Anvar water-soluble immunological adjuvants
US4001395A (en) * 1972-06-20 1977-01-04 Agence Nationale De Valorisation De La Recherche (Anvar) Hydrosoluble extracts of mycobacteria
NL7308450A (https=) * 1972-06-20 1973-12-27
US3976544A (en) * 1973-06-19 1976-08-24 The Agence Nationale De Valorisation De Le Recherche Water-soluble immunological adjuvants, in particular for vaccines, obtained from mycobacteria and related microorganisms and process for their extraction
SU552744A1 (ru) * 1975-12-25 1977-11-05 Московский Научно-Исследовательский Институт Вакцин И Сывороток Им. И.И. Мечникова Министерства Здравоохранения Ссср Способ получени растворимого коклюшного иммуноадъюванта

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2189021A1 (en) * 1972-06-20 1974-01-25 Anvar Non-arthrogenic immunological adjuvants - obtained by extraction of lipid-free mycobacterial residues

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1969 *

Also Published As

Publication number Publication date
DE2908241A1 (de) 1979-09-13
IT7920841A0 (it) 1979-03-08
GB2015876A (en) 1979-09-19
DE2954387C2 (de) 1986-10-09
CA1146467A (en) 1983-05-17
FR2419071B1 (https=) 1983-02-11
DE2908241C2 (de) 1985-10-31
US4726947A (en) 1988-02-23
JPS6241214B2 (https=) 1987-09-02
GB2015876B (en) 1982-08-18
JPS54140710A (en) 1979-11-01
IT1110450B (it) 1985-12-23

Similar Documents

Publication Publication Date Title
FR2419071A1 (fr) Extrait cellulaire bacterien, procede de preparation, preparation antitumorale et preparation adjuvante le contenant
EP0031285A2 (fr) Préparations immunostimulantes à base d'ARN ribosomaux de Klebsiella pneumoniae et procédé de préparation de ces ARN
GB1384179A (en) Treatment of microorganism cells
DE3049308A1 (de) Verfahren zur bildung des enzyms (alpha)-galactoxidase und zur hydrolyse von raffinose unter verwendung dieses enzyms
FR2457292A1 (fr) Purification de riboflavine
US4062943A (en) Antibiotic produced from the microorganism (Pseudomonas lindbergii), its preparation and method of use
GB1298431A (en) Process for the enrichment of proteins
Bailey α-Galactosidase activity of rumen bacteria
NO176327C (no) Fremgangsmåte for fremstilling av riboflavin og stammer av Candida famata for anvendelse deri
EP1012246B1 (de) Fermentationsverfahren mit kontinuierlicher massenkultivierung von ciliaten (protozoa) zur produktion biogener wertstoffe
Schwencke et al. A rapid and reproducible method for obtaining yeast protoplasts
Chilcott et al. The use of coconut wastes for the production of Bacillus thuringiensis var. israelensis
Kothe et al. A taxonomic study of mycolateless, wall chemotype IV actinomycetes
JPS57193415A (en) Preparation of antitumor substance
SU1260005A1 (ru) Способ получени биологически активных веществ,обладающих гепатозащитным действием
EP0252855B1 (fr) Procédé de bioconversion sélective du dinitrate d'isosorbitol
DE3270983D1 (en) Process for preparing a mixture of bee pollen having an improved resorption capacity, and a hyposensibilizing mixture of bee pollen
Graf Presence of bacteria in the posterior caecum in the intestinal lumen of the hypogean Crustacean Niphargus virei(Gammaridae: Amphipoda).).
Ohsugi et al. Biosynthesis of Biotion-vitamers from Pelargonic Acid by Pseudomonas sp.
GB1525451A (en) Method for processing activated sludge into useful products
JPS5765192A (en) Preparation of (+)-beta-hydroxyisobutyric acid
US2885325A (en) Purification of canaigre tannin extracts
JPS54145280A (en) Production of cells of photosynthetic bacterium
FR2398754A1 (fr) Compositions enzymatiques pour l'isomerisation du glucose en levulose
ES405697A1 (es) Un metodo mejorado para descomponer la rafinosa contenida en el zumo de remolacha o en melazas de remolacha, en galac-tosa y sacarosa.

Legal Events

Date Code Title Description
ST Notification of lapse